Form 4 for OGN Organon & Co.
Accepted 2024-03-01 00:00:00 ET · period of report 2024-02-28 · accession 0001821825-24-000009 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-03-01 | 2024-02-28 | OGN | Ali Kevin | CEO, Dir | M - OptEx | — | +88.1K | 138.7K | +174% | — |
| D | 2024-03-01 | 2024-02-28 | OGN | Ali Kevin | CEO, Dir | F - Tax | $18.04 | -40.4K | 98.3K | -29% | -$729.1K |
| D | 2024-03-01 | 2024-02-28 | OGN | Ali Kevin | CEO, Dir | M - OptEx | $0.00 | -88.1K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-28 | M | A | 88,121 | — | 138,740 | D | — | — | (F1) Each Restricted Stock Unit converts into one share of Organon & Co. common stock. |
| 2 | Common | Common Stock | 2024-02-28 | F | D | 40,414 | $18.04 | 98,326 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2024-02-28 | M | D | 88,121 | $0.00 | 0 | D | — · 2023-12-31 to 2023-12-31 | 88,121 Common Stock | (F2) As previously reported, these Restricted Stock Units vested on December 31, 2023, and shares of Organon & Co. common stock were distributed to the Reporting Person on February 28, 2024. (F1) Each Restricted Stock Unit converts into one share of Organon & Co. common stock. |